Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder. | 2014-05-15 |
|
| Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. | 2014-03 |
|
| Simultaneous determination of 25 common pharmaceuticals in whole blood using ultra-performance liquid chromatography-tandem mass spectrometry. | 2012-09 |
|
| Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. | 2012-04-18 |
|
| Severe laryngeal dystonia in a patient receiving zuclopenthixol "Acuphase" and fluoxetine. | 2010-04 |
|
| Remission of schizophrenia psychosis and strong reduction of obsessive-compulsive disorder after adding clozapine to aripiprazole. | 2009-11-13 |
|
| Fatal exertional heat stroke in a patient receiving zuclopenthixol, quetiapine and benztropine. | 2007 |
|
| [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations]. | 2006-06 |
|
| Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia. | 2005-07 |
|
| Pro-oxidant activity of zuclopenthixol in vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats. | 2004-08 |
|
| Zuclopenthixol facilitates memory retrieval in rats: possible involvement of noradrenergic and serotonergic mechanisms. | 2003-07 |
|
| Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs. | 2001-07 |
|
| Clozapine and weight gain. | 2001-05 |
|
| Effect of some psychotropic drugs and a barbiturate on mycoplasmas. | 2000-04 |
|
| [acute dystonias in combined abuse of cocaine and neuroleptics]. | 1994-11-26 |
|
| Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia. | 1991-12 |
|
| Reversible lithium neurotoxicity at normal serum level may refer to intracranial pathology. | 1989-05 |
|
| Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study. | 1989 |
|
| Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study. | 1987-07 |
|
| Prolonged oculogyric crisis on addition of nifedipine to neuroleptic medication regime. | 1987-01 |
|
| The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria. | 1986-12 |
|
| The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy. | 1967 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
211-194-3
Created by
admin on Mon Mar 31 20:24:02 GMT 2025 , Edited by admin on Mon Mar 31 20:24:02 GMT 2025
|
PRIMARY | |||
|
169185
Created by
admin on Mon Mar 31 20:24:02 GMT 2025 , Edited by admin on Mon Mar 31 20:24:02 GMT 2025
|
PRIMARY | |||
|
m3653
Created by
admin on Mon Mar 31 20:24:02 GMT 2025 , Edited by admin on Mon Mar 31 20:24:02 GMT 2025
|
PRIMARY | Merck Index | ||
|
633-59-0
Created by
admin on Mon Mar 31 20:24:02 GMT 2025 , Edited by admin on Mon Mar 31 20:24:02 GMT 2025
|
PRIMARY | |||
|
SUB20303
Created by
admin on Mon Mar 31 20:24:02 GMT 2025 , Edited by admin on Mon Mar 31 20:24:02 GMT 2025
|
PRIMARY | |||
|
DTXSID60110058
Created by
admin on Mon Mar 31 20:24:02 GMT 2025 , Edited by admin on Mon Mar 31 20:24:02 GMT 2025
|
PRIMARY | |||
|
R3BMY435Z0
Created by
admin on Mon Mar 31 20:24:02 GMT 2025 , Edited by admin on Mon Mar 31 20:24:02 GMT 2025
|
PRIMARY | |||
|
100000078003
Created by
admin on Mon Mar 31 20:24:02 GMT 2025 , Edited by admin on Mon Mar 31 20:24:02 GMT 2025
|
PRIMARY | |||
|
78203
Created by
admin on Mon Mar 31 20:24:02 GMT 2025 , Edited by admin on Mon Mar 31 20:24:02 GMT 2025
|
PRIMARY |
All of the following components must be present:
ACTIVE MOIETY
SUBSTANCE RECORD